Cerner Corp (NASDAQ: CERN) reported second-quarter FY21 revenue growth of 10% year-on-year to $1.46 billion, beating the analyst consensus of $1.44 billion. Revenues from Licensed software rose 15.
Cerner (CERN) delivered earnings and revenue surprises of 5.26% and 1.30%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Cerner's (CERN) second-quarter results benefit from gains across six of its business units.

Recap: Cerner Q2 Earnings

08:09am, Friday, 30'th Jul 2021
Shares of Cerner (NASDAQ:CERN) were unchanged after the company reported Q2 results. Quarterly Results Earnings per share increased 26.98% year over year to $0.80, which beat the estimate of $0.76.

Cerner Reports Second Quarter 2021 Results

07:30am, Friday, 30'th Jul 2021
Delivers Strong Results Across All Key Metrics GAAP Operating Margin and Diluted EPS Lower Due to Restructuring Charges Strong Adjusted Operating Margin Expansion and Adjusted Diluted EPS Growth vs. Y
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Cerner's (CERN) second-quarter results are likely to reflect gains from strategic deals.
KANSAS CITY, Mo., July 16, 2021 (GLOBE NEWSWIRE) -- Cerner Corporation (Nasdaq: CERN) today announced it will release its second quarter 2021 earnings results before the market opens Friday, July 30.
Expansion represents commitment to transform patient care across Western Massachusetts Expansion represents commitment to transform patient care across Western Massachusetts
Markets continued their bull rally today after a small setback yesterday, with all three major markets in the green. Make the most of this market with today's Top Buys from Q.ai's artificial intellige
Mainstream cloud vendors backed away from the healthcare space a decade ago, fearful of regulation, but they're now adapting to regulation in their main markets and might want to get back in. The post
Here we look at three stocks, MDRX, CERN and RMD, that investors can keep a watch on the back of their robust digital health prospects.
Growth investors and dividend collectors alike should consider CERN stock now as the company posts indisputably solid fiscal figures. The post Cerner Is a Strong Value Based on Ultra-Firm Financials a
The COVID-19 pandemic has in a way increased the pace of progress of Medical Information Systems industry.
Cerner (CERN) reported earnings 30 days ago. What's next for the stock?
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE